| Q52191627 | (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats. |
| Q73661239 | A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study |
| Q34527972 | A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse |
| Q43857751 | A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task |
| Q28300210 | ADHD and smoking: from genes to brain to behavior |
| Q34304101 | Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior |
| Q37725116 | Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. |
| Q36015224 | Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates |
| Q37363808 | Age dependent nicotinic influences over dopamine neuron synaptic plasticity |
| Q35174622 | Age-related changes in nicotine response of cholinergic and non-cholinergic laterodorsal tegmental neurons: implications for the heightened adolescent susceptibility to nicotine addiction |
| Q30493138 | Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine |
| Q48911423 | Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. |
| Q33933548 | Alteration of the behavioral effects of nicotine by chronic caffeine exposure. |
| Q36900018 | Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking. |
| Q48432702 | Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats |
| Q43857744 | Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine |
| Q35631485 | Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors |
| Q52308086 | Association between catechol-O-methyltransferase (COMT) Val/Met genotype and smoking cessation treatment with nicotine: a meta-analysis. |
| Q47743250 | Association between urine cotinine levels, continuous performance test variables, and attention deficit hyperactivity disorder and learning disability symptoms in school-aged children |
| Q48332007 | Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys |
| Q42276343 | Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus |
| Q30491573 | Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning |
| Q27024840 | Binge eating disorder and food addiction |
| Q34610366 | Biological processes underlying co-use of alcohol and nicotine: neuronal mechanisms, cross-tolerance, and genetic factors. |
| Q28582567 | Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors |
| Q52177843 | Blockade of nicotine self-administration with nicotinic antagonists in rats. |
| Q47162947 | Blockade of nicotine sensitization by methanol extracts of Glycyrrhizae radix mediated via antagonism of accumbal oxidative stress. |
| Q34491952 | Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan |
| Q48650560 | Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward |
| Q43691431 | Brain metabolic effects of acute nicotine |
| Q52171874 | Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells. |
| Q36122868 | Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area |
| Q51980372 | C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. |
| Q31863511 | Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse |
| Q46635637 | Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. |
| Q37247103 | Cellular events in nicotine addiction |
| Q46880169 | Characterization of M-current in ventral tegmental area dopamine neurons |
| Q33691659 | Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter |
| Q36915185 | Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons |
| Q36501908 | Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs |
| Q34058860 | Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity |
| Q52040990 | Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat. |
| Q37412735 | Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors |
| Q42851032 | Cigarettes and addiction |
| Q30474904 | Cognitive effects of nicotine: genetic moderators |
| Q28579050 | Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain |
| Q44069082 | Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys |
| Q36293008 | Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. |
| Q49018787 | Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. |
| Q30505379 | Conditioned response evoked by nicotine conditioned stimulus preferentially induces c-Fos expression in medial regions of caudate-putamen. |
| Q43832288 | Contributory role for nornicotine in nicotine neuropharmacology: nornicotine-evoked [3H]dopamine overflow from rat nucleus accumbens slices |
| Q37188976 | Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats |
| Q24650892 | Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration |
| Q57790904 | Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior |
| Q44418971 | Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. |
| Q73186926 | Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens |
| Q47749175 | Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats. |
| Q41929123 | Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake |
| Q46640365 | Differential involvement of glutamatergic mechanisms in the cognitive and subjective effects of smoking. |
| Q35647302 | Differential roles of α6β2* and α4β2* neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice. |
| Q36184313 | Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). |
| Q38732951 | Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons". |
| Q35129336 | Discriminative and reinforcing stimulus effects of nicotine, cocaine, and cocaine + nicotine combinations in rhesus monkeys |
| Q43614893 | Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats |
| Q34938227 | Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine |
| Q46220422 | Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons |
| Q28586513 | Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice |
| Q37103329 | Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal. |
| Q38204497 | Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation |
| Q28067590 | Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure |
| Q42948457 | Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens |
| Q52290962 | Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. |
| Q24681363 | Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. |
| Q48405857 | Drug-activation of brain reward pathways |
| Q34515669 | Effect of transdermal nicotine administration on exercise endurance in men. |
| Q48307117 | Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats |
| Q36732577 | Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats |
| Q71943026 | Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat |
| Q44539113 | Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis study |
| Q44525598 | Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain |
| Q57380841 | Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers |
| Q46882404 | Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers |
| Q36850568 | Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration |
| Q51840543 | Effects of chronic nicotine, nicotine withdrawal and subsequent nicotine challenges on behavioural inhibition in rats. |
| Q37642452 | Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration |
| Q73713403 | Effects of cotinine at cholinergic nicotinic receptors of the sympathetic superior cervical ganglion of the mouse |
| Q42440283 | Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. |
| Q48374416 | Effects of nornicotine enantiomers on intravenous S(-)-nicotine self-administration and cardiovascular function in rats |
| Q36580797 | Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats |
| Q37121061 | Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats |
| Q52558796 | Electronic cigarette substitution in the experimental tobacco marketplace: A review. |
| Q34961709 | Endogenous cholinergic inputs and local circuit mechanisms govern the phasic mesolimbic dopamine response to nicotine. |
| Q35892732 | Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: modulation by serotonin-3 and nicotinic cholinergic receptors |
| Q37692812 | Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs. |
| Q38112760 | Evolutionary development of neural systems in vertebrates and beyond |
| Q44632886 | Exposure to ethanol and tobacco smoke in relation to level of PCNA antigen expression in pancreatic and hepatic rat cells |
| Q36274171 | Exposure to nicotine and sensitization of nicotine-induced behaviors |
| Q36746564 | Exposure to nicotine increases nicotinic acetylcholine receptor density in the reward pathway and binge ethanol consumption in C57BL/6J adolescent female mice |
| Q33875395 | Functional brain imaging of tobacco use and dependence |
| Q46085969 | Gender differences in the pharmacology of nicotine addiction |
| Q48510920 | Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome. |
| Q36528263 | Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch |
| Q37264547 | Genetic variation in the dopamine pathway and smoking cessation |
| Q34969212 | Genetically expressed HIV-1 viral proteins attenuate nicotine-induced behavioral sensitization and alter mesocorticolimbic ERK and CREB signaling in rats. |
| Q30491854 | Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction |
| Q35353532 | Historical and current perspective on tobacco use and nicotine addiction |
| Q42615631 | How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science |
| Q37520732 | Hypocretin mechanisms in nicotine addiction: evidence and speculation |
| Q47962415 | Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release |
| Q73184561 | Ibogaine and the dopaminergic response to nicotine |
| Q36451065 | Impact of prefrontal cortex in nicotine-induced excitation of ventral tegmental area dopamine neurons in anesthetized rats |
| Q24643170 | In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors |
| Q33946922 | In vivo brain imaging of human exposure to nicotine and tobacco |
| Q34390965 | Inbred mouse strains vary in oral self-selection of nicotine |
| Q44869606 | Individual variability of dopamine release from nucleus accumbens induced by nicotine |
| Q47856884 | Inducibility of c-Fos protein in visuo-motor system and limbic structures after acute and repeated administration of nicotine in the rat. |
| Q64915913 | Inhibition of alpha7 nicotinic receptors in the ventral hippocampus selectively attenuates reinstatement of morphine-conditioned place preference and associated changes in AMPA receptor binding. |
| Q37146387 | Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats |
| Q35757268 | Intra-ventral tegmental area HIV-1 Tat1-86 attenuates nicotine-mediated locomotor sensitization and alters mesocorticolimbic ERK and CREB signaling in rats |
| Q34543525 | Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons. |
| Q57380107 | Investigating possible causal effects of externalizing behaviors on tobacco initiation: A Mendelian randomization analysis |
| Q37315470 | Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation |
| Q36666651 | It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood |
| Q35598427 | Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system |
| Q28281281 | L-theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathway |
| Q36574129 | Lifestyle Factors and Risk of Restless Legs Syndrome: Prospective Cohort Study |
| Q48364549 | Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. |
| Q48233950 | Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study |
| Q42468426 | Local perfusion of nicotine differentially modulates somatodendritic dopamine release in the rat ventral tegmental area after nicotine preexposure |
| Q37166530 | Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning. |
| Q28513200 | Long-term effects of chronic nicotine exposure on brain nicotinic receptors |
| Q51381056 | Long-term potentiation of excitatory inputs to brain reward areas by nicotine. |
| Q28484969 | Low dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in mice |
| Q36406661 | Marijuana and tobacco exposure predict affect-regulation expectancies in dual users |
| Q37018610 | Mechanism-based medication development for the treatment of nicotine dependence. |
| Q27687645 | Mechanistic insights into nicotine withdrawal |
| Q46364764 | Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement |
| Q92556851 | Menstrual cycle phase modulates responses to smoking cues in the putamen: Preliminary evidence for a novel target |
| Q36870245 | Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal |
| Q47663907 | Metabotropic Glutamate Receptors 2 and 3 as Targets for Treating Nicotine Addiction. |
| Q35291239 | Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats |
| Q37508580 | Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms |
| Q44080843 | Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors |
| Q28564628 | Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei |
| Q26851972 | Molecular mechanisms underlying behaviors related to nicotine addiction |
| Q37327392 | Molecular mechanisms underlying the motivational effects of nicotine |
| Q41770343 | N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity |
| Q48522936 | N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens |
| Q37125141 | NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala |
| Q35217772 | Narcolepsy with cataplexy associated with nocturnal compulsive behaviors: a case-control study |
| Q36969243 | Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration |
| Q48366277 | Neural substrate of nicotine addiction as defined by functional brain maps of gene expression |
| Q91991315 | Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse |
| Q34390258 | Neurobiology of addiction |
| Q34498032 | Neurobiology of the nicotine withdrawal syndrome |
| Q33673243 | Neurobiology of tobacco smoking and other addictive disorders |
| Q77844604 | Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives |
| Q34342747 | Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q34616154 | Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. |
| Q39059946 | Neuropeptide systems and new treatments for nicotine addiction |
| Q36376434 | Neuropharmacology and potential efficacy of new treatments for tobacco dependence |
| Q33609822 | Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. |
| Q58183149 | Nicotine Self-Administration in Animals: A Reevaluation |
| Q48590165 | Nicotine activates and desensitizes midbrain dopamine neurons |
| Q33704745 | Nicotine addiction. |
| Q34131414 | Nicotine and bupropion share a similar discriminative stimulus effect |
| Q41835696 | Nicotine and cocaine self-administration using a multiple schedule of intravenous drug and sucrose reinforcement in rats |
| Q28111990 | Nicotine and endogenous opioids: Neurochemical and pharmacological evidence |
| Q40867544 | Nicotine and endogenous opioids: toward specific pharmacotherapy |
| Q48590663 | Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens |
| Q37381294 | Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability |
| Q46976567 | Nicotine dependence syndrome scale and craving: comparing nicotine-dependent individuals with and without comorbid alcohol dependence |
| Q49723355 | Nicotine drug discrimination and nicotinic acetylcholine receptors in differentially reared rats |
| Q44588983 | Nicotine enhances responding with conditioned reinforcement |
| Q48366302 | Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons |
| Q35846864 | Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing α4 and α6 subunits |
| Q43125451 | Nicotine provokes impulsive-like action by stimulating alpha4beta2 nicotinic acetylcholine receptors in the infralimbic, but not in the prelimbic cortex |
| Q45763902 | Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area. |
| Q33704751 | Nicotine replacement therapy |
| Q45791809 | Nicotine self-administered directly into the VTA by rats is weakly reinforcing but has strong reinforcement enhancing properties |
| Q35121048 | Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. |
| Q52310419 | Nicotine self-administration remodels perineuronal nets in ventral tegmental area and orbitofrontal cortex in adult male rats. |
| Q30244252 | Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research |
| Q28139928 | Nicotine, brain nicotinic receptors, and neuropsychiatric disorders |
| Q44126618 | Nicotine-induced conditioned place preference in adolescent and adult rats |
| Q45032449 | Nicotine-induced enhancement of responding for conditioned reinforcement in rats: role of prior nicotine exposure and α4β2 nicotinic receptors |
| Q51972810 | Nicotine-induced fos expression in the pedunculopontine mesencephalic tegmentum in the rat. |
| Q37525085 | Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction |
| Q38645039 | Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations |
| Q94059614 | Nicotinic Receptor Intervention in Parkinson's Disease: Future Directions |
| Q33894536 | Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function |
| Q42186953 | Nicotinic acetylcholine receptors are required for the conditioned reinforcing properties of sucrose-associated cues |
| Q35591662 | Nicotinic acetylcholine receptors containing α6 subunits contribute to alcohol reward-related behaviours |
| Q43099250 | Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. |
| Q37387682 | Nicotinic activation of laterodorsal tegmental neurons: implications for addiction to nicotine |
| Q34631254 | Nicotinic alpha 7 receptors as a new target for treatment of cannabis abuse |
| Q35541262 | Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction |
| Q34459004 | Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization |
| Q37533310 | Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits |
| Q48587669 | Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats. |
| Q35966896 | Nicotinic receptor contributions to smoking: insights from human studies and animal models |
| Q37404292 | Nicotinic receptors and stages of nicotine dependence. |
| Q51406614 | Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically. |
| Q37055419 | Nominal association with CHRNA4 variants and nicotine dependence |
| Q59050953 | Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison |
| Q33704755 | Non-nicotine pharmacotherapy for smoking cessation |
| Q43846372 | Nornicotine, a nicotine metabolite and tobacco alkaloid: desensitization of nicotinic receptor-stimulated dopamine release from rat striatum |
| Q36035895 | Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. |
| Q48429046 | Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine |
| Q36708951 | Overview of the pharmacogenomics of cigarette smoking |
| Q34239996 | Patterns of nicotinic receptor antagonism II: cardiovascular effects in rats |
| Q35265699 | Patterns of nicotinic receptor antagonism: nicotine discrimination studies |
| Q51439014 | Periadolescent nicotine exposure reduces cocaine reward in adult mice. |
| Q36087706 | Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation |
| Q38345693 | Pharmacogenetics of nicotine and associated smoking behaviors |
| Q35022995 | Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials |
| Q37395740 | Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes |
| Q34104228 | Pharmacology and behavioral pharmacology of the mesocortical dopamine system |
| Q40955351 | Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders |
| Q36183703 | Polygenic Score × Intervention Moderation: an Application of Discrete-Time Survival Analysis to Model the Timing of First Marijuana Use Among Urban Youth |
| Q40254027 | Polygenic score × intervention moderation: an application of discrete-time survival analysis to modeling the timing of first tobacco use among urban youth |
| Q37230901 | Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration |
| Q34359231 | Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system |
| Q27021772 | Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype |
| Q42488958 | Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration |
| Q37014100 | Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission |
| Q34398910 | Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area |
| Q73850702 | Prolonged changes in neurochemistry of dopamine neurones after chronic ethanol consumption |
| Q37699703 | Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence |
| Q26999059 | Rapid, transient synaptic plasticity in addiction |
| Q35425270 | Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence |
| Q43823224 | Rats prefer cocaine over nicotine in a two-lever self-administration choice test. |
| Q48317236 | Receptor systems participating in nicotine-specific effects |
| Q34124179 | Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens |
| Q24792017 | Reduced inhibitory action of a GABAB receptor agonist on [3H]-dopamine release from rat ventral tegmental area in vitro after chronic nicotine administration |
| Q45272359 | Reduced nicotine reward in obesity: cross-comparison in human and mouse |
| Q36484647 | Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo |
| Q35762334 | Region-specific mechanisms for testosterone-induced Fos in hamster brain |
| Q48725622 | Regional variation in the effects of nicotine on catecholamine overflow in rat brain |
| Q37024161 | Review. Neurobiology of nicotine dependence |
| Q33927226 | Reward deficiency syndrome: genetic aspects of behavioral disorders |
| Q28214622 | Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area |
| Q44390915 | Rewarding injections of the cholinergic agonist carbachol into the ventral tegmental area induce locomotion and c-Fos expression in the retrosplenial area and supramammillary nucleus. |
| Q35121761 | Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. |
| Q30551483 | Role of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotine |
| Q60339308 | Role of Calcineurin in Nicotine-Mediated Locomotor Sensitization |
| Q34002770 | Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness |
| Q33894548 | Role of dopamine in the behavioural actions of nicotine related to addiction |
| Q37242594 | Role of the glutamatergic system in nicotine dependence : implications for the discovery and development of new pharmacological smoking cessation therapies |
| Q50647796 | Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration. |
| Q35690145 | Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders |
| Q37505422 | Secondhand Smoke Exposure and Low Blood Lead Levels in Association With Attention-Deficit Hyperactivity Disorder and Its Symptom Domain in Children: A Community-Based Case-Control Study. |
| Q37025119 | Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine |
| Q34310032 | Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration |
| Q48469856 | Sensitization of the mesoaccumbens dopamine response to nicotine |
| Q41808597 | Sex differences in neurotensin and substance P following nicotine self-administration in rats. |
| Q45245208 | Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats. |
| Q34255025 | Sex, ADHD symptoms, and smoking outcomes: an integrative model |
| Q34459334 | Stimulation of α2-adrenergic receptors in the central nucleus of the amygdala attenuates stress-induced reinstatement of nicotine seeking in rats |
| Q34524803 | Striatal dopamine neurotransmission: regulation of release and uptake |
| Q30487079 | Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. |
| Q28506626 | Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice |
| Q43925474 | Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas |
| Q34953245 | Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence |
| Q35837700 | The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control |
| Q37189885 | The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers |
| Q48143336 | The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol. |
| Q50061753 | The Role of Cognitive Control in the Self-Regulation and Reinforcement of Smoking Behavior |
| Q51980369 | The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. |
| Q44916561 | The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice |
| Q89450421 | The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data |
| Q33933562 | The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? |
| Q41052058 | The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine |
| Q37291517 | The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. |
| Q40938769 | The incentive amplifying effects of nicotine are reduced by selective and non-selective dopamine antagonists in rats |
| Q42259547 | The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats |
| Q44304048 | The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor |
| Q37610462 | The multiple facets of cigarette addiction and what they mean for encouraging and helping smokers to stop |
| Q34988448 | The necessity of α4* nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine |
| Q35621339 | The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour |
| Q36741890 | The neurocircuitry of addiction: an overview |
| Q48594630 | The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access |
| Q51363792 | The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. |
| Q73572188 | The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study |
| Q42409477 | The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections |
| Q37416390 | The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal |
| Q48157802 | The role of beta 2-subunit-containing nicotinic acetylcholine receptors in the brain explored with a mutant mouse |
| Q48116153 | The role of conditioning history and reinforcer strength in the reinforcement enhancing effects of nicotine in rats |
| Q38338790 | The role of mesoaccumbens dopamine in nicotine dependence |
| Q48711248 | The role of monoamine neurotransmitter systems in the nicotine discriminative stimulus |
| Q42082758 | The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine. |
| Q37066079 | The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions |
| Q34634505 | The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-d-aspartate receptors |
| Q33417780 | Tobacco and psychiatric dual disorders |
| Q34444437 | Tobacco dependence, the insular cortex and the hypocretin connection |
| Q36650308 | Tobacco smoke exposure induces nicotine dependence in rats |
| Q36906670 | Translational research in medication development for nicotine dependence |
| Q44784955 | Update on the treatment of tobacco dependence |
| Q34553486 | Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration |
| Q28576280 | Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum |
| Q35583364 | Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens |
| Q34919642 | bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse |
| Q43910677 | c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery |
| Q89059740 | c-Fos marking of identified midbrain neurons coactive after nicotine administration in-vivo |
| Q36517174 | α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief |